Publication | Closed Access

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

Cmet MutationsOncologyLow-volume BiopsiesTumor HeterogeneityMedicinePathologyCancer GenomicsBronchial NeoplasmCancer GeneticsMolecular DiagnosticsRadiation OncologyLung CancerTumor BiologyWhole Genome AmplificationHealth Sciences